Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    27-September-2000      
Issue 167 Next Update - 14:00 UTC 08:00 EST    28-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya FDA Approves New Glue For Use In Brain Surgery

Glue May Decrease Incidence Of Hemorrhage, Stroke And Death

The FDA approved a new glue for use in a rare form of brain surgery performed when the blood vessels in the brain are intertwined, putting patients at risk of stroke and death.

The glue, made by Cordis Neurovascular Inc., of Miami Lakes, Fla., was approved for use in patients at risk of hemorrhaging and dying from cerebral arteriovenous malformations (AVMs) to reduce blood loss by blocking blood vessels in the brain before surgery.

The glue is infused into the blood vessels via a catheter inserted into the leg and threaded up to the brain. Later, the glue is removed during surgery to remove the AVM.

Approval of the product, Trufill n-BCA Liquid Embolic System, was based on a review of pre-clinical and clinical studies of safety and effectiveness conducted by Cordis and on the recommendation of the Neurological Devices Panel of FDA's Medical Devices Advisory Committee.

The firm's multi-center study of 104 patients showed that the glue was as effective in blocking blood flow as standard treatment with poly- vinyl alcohol. In the study, half the patients were treated with the glue; half with poly-vinyl alcohol. Both groups had about the same rate of complications.

Approximately 4,000 cerebral AVM procedures are performed each year in the United States.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.